MGROF (MustGrow Biologics) YoY EBITDA Growth: 37.50% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MGROF MustGrow Biologics Corp MGROF
24 GF Score
Price $0.31
! 3 Warning Signs
View Full Analysis

What is MustGrow Biologics YoY EBITDA Growth?

MustGrow Biologics MGROF +2.07% 24 YoY EBITDA Growth is 37.50% as of Mar. 2026. GuruFocus rates MGROF with a GF Score™ of 24/100. The stock has 3 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. MustGrow Biologics's YoY EBITDA Growth for the quarter that ended in Mar. 2026 was 37.50%.

MustGrow Biologics's EBITDA per Share for the three months ended in Mar. 2026 was $-0.01.

MustGrow Biologics YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for MustGrow Biologics's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MustGrow Biologics YoY EBITDA Growth Chart

MustGrow Biologics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.59 -53.70 85.54 -458.33 -37.31

MustGrow Biologics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.67 0.00 -33.33 -62.50 37.50
MGROF
24GF Score
MustGrow Biologics Corp MGROF
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MustGrow Biologics YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

MustGrow Biologics's YoY EBITDA Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (A: Dec. 2025 )
=(EBITDA per Share (A: Dec. 2025 )-EBITDA per Share (A: Dec. 2024 ))/ | EBITDA per Share (A: Dec. 2024 ) |
=(-0.092--0.067)/ | -0.067 |
=-37.31 %

MustGrow Biologics's YoY EBITDA Growth for the quarter that ended in Mar. 2026 is calculated as:

YoY EBITDA Growth (Q: Mar. 2026 )
=(EBITDA per Share (Q: Mar. 2026 )-EBITDA per Share (Q: Mar. 2025 )) / | EBITDA per Share (Q: Mar. 2025 )) |
=(-0.01--0.016)/ | -0.016 |
=37.50 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 37.50% mean?
MustGrow Biologics (MGROF) has a YoY EBITDA Growth of 37.50% as of Mar. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for MustGrow Biologics and its competitors.
Is MustGrow Biologics' YoY EBITDA Growth too high?
MustGrow Biologics' current YoY EBITDA Growth is 37.50%. Overall, MustGrow Biologics has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does MustGrow Biologics' YoY EBITDA Growth compare to CTVA and CF?
MustGrow Biologics' YoY EBITDA Growth of 37.50% can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for an Agriculture company?
A good YoY EBITDA Growth depends on the Agriculture industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for MustGrow Biologics and its competitors. MustGrow Biologics's current YoY EBITDA Growth is 37.50%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MustGrow Biologics stock overvalued right now?
MustGrow Biologics (MGROF) has a current YoY EBITDA Growth of 37.50%. The current YoY EBITDA Growth is 37.50%. MustGrow Biologics' overall GF Score™ is 24/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For MustGrow Biologics (MGROF), the current YoY EBITDA Growth is 37.50% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MustGrow Biologics Business Description

Other Exchanges 0C0:GermanyMGRO:Canada
Address 1005 - 201 1st Avenue South, Saskatoon, SK, CAN, S7K 1J5
MustGrow Biologics Corp is a fully integrated provider of biological and regenerative agriculture solutions designed to support sustainable farming. The Company's proprietary and third-party product lines offer eco-friendly alternatives to restricted or banned synthetic chemicals and fertilizers. It offers a portfolio of third-party crop nutrition solutions, including micronutrients, nitrogen stabilizers, biostimulants, and foliar products. These products are synergistically distributed alongside MustGrow's wholly owned proprietary products and technologies that are derived from mustard and developed into organic biocontrol and biofertility products to help replace banned or restricted synthetic chemicals and fertilizers.
24GF Score

Get the complete analysis for MGROF

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.31
Price